Non-vascular stents are a series of devices used in a variety of applications, including implants of the esophagus, bile ducts, colon, trachea, and bronchi. Non-vascular stents are implanted by minimally invasive surgery. Minimally invasive surgery can speed recovery while reducing pain and shortening the length of your hospital stay. Nonvascular stents are increasingly being used in a variety of applications, such as treating lung, urinary system, and gastrointestinal diseases. The use of these stents in neurology and ophthalmology is also increasing.
The global non-vascular stents market was valued at US$ 934.7 million in 2017 and is expected to grow at a CAGR of 4.7% during the forecast period (2017-2025).
Get PDF Brochure with COVID19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1340
The growing demand for minimally invasive surgery is expected to be a major factor driving the growth of the global non-vascular stents market. Non-vascular stents involve small and precise incisions, resulting in relatively small and less obvious scars during traditional surgical procedures that endanger patient safety. This procedure is associated with faster recovery time, thereby reducing the patient’s hospital stay. In addition, it is expected that the reduction in hospital stay will reduce the risk of patients getting hospital-acquired infections (such as bloodstream infections, urinary tract infections, etc.). These factors are considered to be the main driving factors for the growth of the global non-vascular stents market.
Increasing prevalence of gastrointestinal, urinary system, and lung or airway diseases is expected to drive the demand for the global non-vascular stents market. Diseases such as chronic obstructive pulmonary disease (COPD), central airway obstruction, and asthma require the use of lung stents to open narrow airways and promote the breathing process. According to data from the World Health Organization, more than 3 million people worldwide die from COPD every year, and 90% of deaths occur in low- and middle-income countries. In addition, in the U.S., kidney disease causes more deaths than prostate cancer or breast cancer each year. These diseases are usually treated palliatively through the use of non-vascular stents. In recent years, non-vascular stents have become the standard treatment for removing tumors in the gastrointestinal system.
The continuous advancement of technology and materials is helping to develop specially designed stents for various indications, and the demand for widely used non-vascular stents is increasing. The development of biodegradable polymers and bioabsorbable stents is increasing the use of stents in lung, gastrointestinal, urinary and biliary strictures. Polycaprolactone, Polyacrylamide, and Polylactic Glycolic Acids are the few newly designed biodegradable scaffold materials without the need to remove the scaffold. Nitinol is increasingly used in non-vascular self-expanding stents due to its super elasticity, which makes it easy to place stents in difficult parts of the internal tubing.
However, the high cost of non-vascular stents is expected to have a negative impact on the growth of the market.
Major Players Are: Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, s.r.o, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena, Inc.
Purchase This Premium Report Here With Discounted Price (Flat US $2000 Off) – https://www.coherentmarketinsights.com/promo/buynow/1340
Reasons to Purchase this Report
• Current and future of global Non-vascular Stents market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027